From Bio (377220) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, From Bio (377220) reported revenue of 72.2 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
202572.2 billion KRW-18.6 billion KRW-23.2 billion KRW[source]
202467.2 billion KRW-24.3 billion KRW-26.2 billion KRW[source]
202366.7 billion KRW-15.4 billion KRW-11.6 billion KRW[source]
202299.3 billion KRW897 million KRW1.3 billion KRW[source]
2021135.1 billion KRW11.4 billion KRW11.3 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
202567.5 billion KRW34.3 billion KRW33.3 billion KRW[source]
202484.5 billion KRW28.7 billion KRW55.8 billion KRW[source]
202398.9 billion KRW19.5 billion KRW79.4 billion KRW[source]
202294.6 billion KRW4.6 billion KRW90.1 billion KRW[source]
202196.4 billion KRW12.0 billion KRW84.4 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice